Clonal Dynamics of Chronic Lymphocytic Leukaemia Treated With Pirtobrutinib After Previous Treatment With Zanubrutinib

Clinical trial NCT06812715 · RECRUITING

Trial details

NCT number: NCT06812715
Sponsor: Peter MacCallum Cancer Centre, Australia
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Chronic Lymphocytic Leukemia

Start date: 2025-05-05
Primary completion: 2029-05-01
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.